Ovira Pty Ltd – Trademark Portfolio
Entity Type: 82
Ovira Pty Ltd holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 5 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include NOHA, OVIRA, LUNEXA, VITX23, and JUNICLEAR.
23 Twisden Rd
Bentleigh VIC 3204
Showing of trademarks Trademarks
Trademark Classifications
Ovira Pty Ltd's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Ovira Pty Ltd have?
Ovira Pty Ltd has 14 U.S. trademarks filed with the USPTO. Of these, 10 registered, 4 abandoned.
What trademark classes does Ovira Pty Ltd file in?
Ovira Pty Ltd files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Ovira Pty Ltd's most well-known trademarks?
Ovira Pty Ltd's registered trademark portfolio includes well-known marks such as NOHA, OVIRA, LUNEXA, VITX23, and JUNICLEAR. These are among 10 currently registered trademarks in the portfolio.
What is Ovira Pty Ltd's trademark registration success rate?
Ovira Pty Ltd has a 71% trademark registration rate, with 10 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.